Clinical Trial Update: Evaluation of the Automatic Deformable Recontouring on the Daily MVCT for Head and Neck Cancer Adaptive Radiotherapy [NA]

View source ↗

Summary

The clinical trial evaluating automatic deformable recontouring on daily MVCT for head and neck cancer adaptive radiotherapy has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Snippet

Sponsor: Institut Claudius Regaud | Conditions: Head and Neck Cancer | NA | Status: WITHDRAWN